Policy Brief

In this policy brief, we describe the impact of PBMs on community pharmacies, state and federal legislation to address PBM practices, and California pharmacists’ experience with current PBM drug reimbursement practices.

Doxycycline Post-exposure Prophylaxis better known as Doxy-PEP is a recently introduced sexually transmitted infection (STI) prevention option. Extending access to Doxy-PEP to more individuals within communities for whom it is recommended merits consideration.

Key updates to PrEP access include recent changes to state and federal law and policy. This summary includes changes likely to affect PrEP access in California.

A new CHPRC analysis evaluates the quality of the HIV-related information provided by ChatGPT and other popular chatbots powered by artificial intelligence (AI) and the extent to which these chatbots tailor their responses to address diverse HIV prevention needs.

Policy brief based on a study of seven California emergency departments (ED) implementing HIV Prevention Services (HPS) linkage programs. Three models for integrating HPS into the ED were identified and may serve as a guide for future protocol development.

Policy Brief Impact of the Inflation Reduction Act on the 340B Program December 4, 2023 The 340b program provides an important revenue source for many HIV clinics and facilities, but that revenue is dependent on drug pricing. The Inflation Reduction Act of 2022 introduced provisions to curb drug pricing. Our modeling suggests that 340b revenues […]

Policy Brief Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment October 20, 2023 A new CHPRC analysis reveals California pharmacists’ preferences for implementing pharmacist-initiated PrEP for HIV prevention under Senate Bill 159. In a discrete choice experiment, pharmacists preferred implementation scenarios in which they play an active role in the […]

Policy Brief An Analysis of the Scientific Evaluation of Orange County’s Discontinued Sterile Syringe Distribution Program and Its Implications for Drug Policy in California August 17, 2023 This brief analyzes the impact of Orange County’s sterile syringe distribution program on client and community outcomes, and also assesses how its impact influenced risk of HIV and […]

Policy Brief Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention? July 31, 2023 A new CHPRC analysis finds strong potential to increase access to long-acting injectable forms of HIV prevention in California pharmacies. Pharmacists surveyed were highly supportive of pharmacy-based PrEP provision under Senate Bill 159, and more […]

Policy Brief People Living With HIV who Smoke Face Barriers to Accessing Smoking Cessation Services in Southern California HIV Safety Nets May 15, 2023 A new study from the California HIV/AIDS Policy Research Centers finds that less than 30% of safety net providers in the Ryan White HIV/AIDS Program in Southern California offered smoking cessation […]